GlassScriptPhysician profile
Wesley R Bray
NPI 1821013087
$1,820.24
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,009 · 2020: $491 · 2021: $171 · 2023: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $150.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $434.19 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $314.57 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $203.31 | 2019-2023 | |
| Insmed, INC. | $155.14 | 2019 | |
| Mylan Specialty L.P. | $128.70 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $121.85 | 2019 | |
| Grifols USA, LLC | $71.60 | 2020 | |
| Mallinckrodt Enterprises LLC | $56.85 | 2019 | |
| Philips North America LLC | $44.31 | 2020-2021 | |
| Advanced Respiratory, INC | $40.53 | 2020 | |
| Novartis Pharmaceuticals Corporation | $36.60 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $35.45 | 2019 | |
| Electromed, INC. | $32.24 | 2019 | |
| Ambu INC. | $25.56 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.24 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $19.39 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $18.54 | 2019 | |
| Allergan, INC. | $17.75 | 2020 | |
| Aroa Biosurgery Incorporated | $17.50 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.81 | 2021 | |
| Fisher & Paykel Healthcare INC | $12.11 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Bray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.